{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:21:15Z","timestamp":1793816475383,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["445325\/2014-3"],"award-info":[{"award-number":["445325\/2014-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.07.170","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:50:20Z","timestamp":1533559820000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats"],"prefix":"10.1016","volume":"107","author":[{"given":"Carmen","family":"Castardeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmem Lu\u00edza","family":"Sart\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enildo Broetto","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-0503","authenticated-orcid":false,"given":"Ludmila","family":"Forechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-368X","authenticated-orcid":false,"given":"Jos\u00e9 Geraldo","family":"Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2018.07.170_bib0005","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1590\/S0100-879X2011007500096","article-title":"Remodeling in the ischemic heart: the stepwise progression for heart failure","volume":"44","author":"Mill","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"7","key":"10.1016\/j.biopha.2018.07.170_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.170_bib0015","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/01.hjh.0000165623.72310.dd","article-title":"The cardiovascular continuum and renin-angiotensin-aldosterone system blockade","volume":"23","author":"Dzau","year":"2005","journal-title":"J. Hypertens. Suppl."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40256-013-0058-8","article-title":"Differences in the clinical effects of angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers: a critical review of the evidence","volume":"14","author":"Dezsi","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"21","key":"10.1016\/j.biopha.2018.07.170_bib0025","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1042\/CS20160193","article-title":"Angiotensin-(1-7) decreases the expression of collagen I via TGF-beta1\/Smad2\/3 and subsequently inhibits fibroblast-myofibroblast transition","volume":"130","author":"Zhou","year":"2016","journal-title":"Clin. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2018.07.170_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"10.1016\/j.biopha.2018.07.170_bib0035","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.170_bib0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijcard.2009.11.057","article-title":"Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure","volume":"145","author":"Ohtsuki","year":"2010","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0050","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.107.100693","article-title":"Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology","volume":"51","author":"Der Sarkissian","year":"2008","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.biopha.2018.07.170_bib0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/hum.2009.160","article-title":"ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction","volume":"21","author":"Zhao","year":"2010","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.170_bib0060","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hernandez Prada","year":"2008","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.biopha.2018.07.170_bib0065","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057111413919","article-title":"Prediction of off-target effects on angiotensin-converting enzyme 2","volume":"16","author":"Kulemina","year":"2011","journal-title":"J. Biomol. Screen."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.170_bib0070","first-page":"129","article-title":"[Trypanosomiasis and babesiasis in Africa and their treatment with the new preparation berenil]","volume":"6","author":"Bauer","year":"1955","journal-title":"Zeitschrift fur Tropenmedizin und Parasitologie"},{"issue":"7\u20138","key":"10.1016\/j.biopha.2018.07.170_bib0075","first-page":"605","article-title":"[Mechanism of action of berenil (4,4\u2019-diamidino-diazoaminobenzol) on Trypanosoma congolense], Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie","volume":"172","author":"Bauer","year":"1958","journal-title":"Originale"},{"key":"10.1016\/j.biopha.2018.07.170_bib0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.phrs.2015.10.005","article-title":"Diminazene aceturate\u2013An antiparasitic drug of antiquity: advances in pharmacology & therapeutics","volume":"102","author":"da Silva Oliveira","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","article-title":"Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology","volume":"62","author":"Qi","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.170_bib0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.euje.2004.07.005","article-title":"Lateral vs medial mitral annular tissue Doppler in the echocardiographic assessment of diastolic function and filling pressures: which should we use?","volume":"6","author":"Srivastava","year":"2005","journal-title":"Eur. J. Echocardiogr."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.170_bib0095","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/cvr\/24.9.748","article-title":"Changes in performance of the surviving myocardium after left ventricular infarction in rats","volume":"24","author":"Mill","year":"1990","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/FJC.0b013e31818a2bb0","article-title":"Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats","volume":"52","author":"Baldo","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S1807-59322011000300020","article-title":"Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake","volume":"66","author":"Baldo","year":"2011","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0110","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.49.3.618","article-title":"Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function","volume":"49","author":"Fletcher","year":"1981","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1590\/S0100-879X2008005000007","article-title":"Determination of myocardial infarction size in rats by echocardiography and tetrazolium staining: correlation, agreements, and simplifications","volume":"41","author":"dos Santos","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.170_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12298","article-title":"Effect of different drug classes on reverse remodeling of intramural coronary arterioles in the spontaneously hypertensive rat","volume":"24","author":"Mancini","year":"2017","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.170_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jash.2014.11.006","article-title":"Effects of high and low salt intake on left ventricular remodeling after myocardial infarction in normotensive rats","volume":"9","author":"Forechi","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1734-1140(11)70613-2","article-title":"Long-term use of low-dose spironolactone in spontaneously hypertensive rats: effects on left ventricular hypertrophy and stiffness","volume":"63","author":"Baldo","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.170_bib0135","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0735-1097(02)01804-1","article-title":"Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction","volume":"39","author":"Zornoff","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153479","article-title":"Right ventricular systolic dysfunction is common in hypertensive heart failure: a prospective study in Sub-Saharan Africa","volume":"11","author":"Ojji","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.170_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cvr\/cvr036","article-title":"Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit","volume":"91","author":"Bodiga","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/187152907782793545","article-title":"Role of PI3 kinase gamma in excitation-contraction coupling and heart disease","volume":"7","author":"Oudit","year":"2007","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.170_bib0155","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.biopha.2018.07.170_bib0160","first-page":"H1985","article-title":"Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats","volume":"284","author":"Sampaio","year":"2003","journal-title":"Am. J. Physiol."},{"issue":"19","key":"10.1016\/j.biopha.2018.07.170_bib0165","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.170_bib0170","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/hrt.2005.062950","article-title":"Current perspectives in diastolic dysfunction and diastolic heart failure","volume":"92","author":"Leite-Moreira","year":"2006","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.biopha.2018.07.170_bib0175","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"Diez","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.170_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/micc.12159","article-title":"Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels","volume":"22","author":"Carver","year":"2015","journal-title":"Microcirculation"},{"issue":"7","key":"10.1016\/j.biopha.2018.07.170_bib0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0190","first-page":"H1900","article-title":"Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction","volume":"293","author":"Xu","year":"2007","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.170_bib0195","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.170_bib0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/cvr\/cvn230","article-title":"Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction","volume":"81","author":"Ainscough","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.170_bib0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ajh.2010.51","article-title":"Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats","volume":"23","author":"Trask","year":"2010","journal-title":"Am. J. Hypertens."},{"issue":"9","key":"10.1016\/j.biopha.2018.07.170_bib0210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cardfail.2010.04.002","article-title":"Effects of ACE2 inhibition in the post-myocardial infarction heart","volume":"16","author":"Kim","year":"2010","journal-title":"J. Card. Fail."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:45:48Z","timestamp":1766025948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221832256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":42,"alternative-id":["S075333221832256X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.170","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}